Wells Fargo & Company Iradimed Corp Transaction History

Wells Fargo & Company

$433 Billion
Q4 2024

A detailed history of Wells Fargo & Company transactions in Iradimed Corp stock. As of the latest transaction made, Wells Fargo & Company holds 4,362 shares of IRMD stock, worth $245,318. This represents 0.0% of its overall portfolio holdings.

Number of Shares

4,362

Previous 3,092 41.07%

Holding current value

$245,318

Previous $155,000 54.19%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 12, 2025	BUY	$48.3 - $57.35 $61,341 - $72,834	1,270 Added 41.07%	4,362 $239,000
Q3 2024 Nov 13, 2024	SELL	$43.23 - $50.29 $2,723 - $3,168	-63 Reduced 2.0%	3,092 $155,000
Q2 2024 Aug 13, 2024	SELL	$40.36 - $44.7 $968 - $1,072	-24 Reduced 0.75%	3,155 $138,000
Q1 2024 May 10, 2024	BUY	$41.17 - $47.29 $7,534 - $8,654	183 Added 6.11%	3,179 $139,000
Q4 2023 Feb 09, 2024	BUY	$37.31 - $47.47 $16,155 - $20,554	433 Added 16.89%	2,996 $142,000
Q3 2023 Nov 13, 2023	SELL	$43.28 - $50.3 $68,468 - $79,574	-1,582 Reduced 38.17%	2,563 $113,000
Q2 2023 Aug 15, 2023	BUY	$38.88 - $50.61 $60,691 - $79,002	1,561 Added 60.41%	4,145 $197,000
Q1 2023 May 12, 2023	BUY	$28.48 - $42.14 $38,932 - $57,605	1,367 Added 112.33%	2,584 $101,000
Q4 2022 Feb 13, 2023	SELL	$26.9 - $30.58 $12,696 - $14,433	-472 Reduced 27.95%	1,217 $34,000
Q3 2022 Nov 14, 2022	SELL	$29.42 - $42.25 $1,559 - $2,239	-53 Reduced 3.04%	1,689 $51,000
Q2 2022 Aug 12, 2022	SELL	$30.15 - $45.79 $582,920 - $885,303	-19,334 Reduced 91.73%	1,742 $60,000
Q1 2022 May 16, 2022	SELL	$36.01 - $53.14 $100,467 - $148,260	-2,790 Reduced 11.69%	21,076 $945,000
Q4 2021 Feb 14, 2022	BUY	$32.35 - $48.27 $190,800 - $284,696	5,898 Added 32.83%	23,866 $1.1 Million
Q3 2021 Nov 15, 2021	BUY	$29.5 - $37.21 $493,181 - $622,076	16,718 Added 1337.44%	17,968 $604,000
Q2 2021 Aug 16, 2021	SELL	$24.04 - $29.79 $133,470 - $165,394	-5,552 Reduced 81.62%	1,250 $37,000
Q1 2021 May 13, 2021	SELL	$22.3 - $26.02 $216,176 - $252,237	-9,694 Reduced 58.77%	6,802 $175,000
Q4 2020 Feb 09, 2021	SELL	$20.62 - $25.0 $45,240 - $54,850	-2,194 Reduced 11.74%	16,496 $376,000
Q3 2020 Nov 05, 2020	SELL	$21.0 - $24.61 $104,118 - $122,016	-4,958 Reduced 20.97%	18,690 $400,000
Q2 2020 Aug 13, 2020	BUY	$18.68 - $24.35 $212,839 - $277,443	11,394 Added 92.98%	23,648 $549,000
Q1 2020 May 14, 2020	BUY	$16.08 - $27.67 $197,044 - $339,068	12,254 New	12,254 $261,000

Others Institutions Holding IRMD

# of Institutions

165

Shares Held

6.78M

Call Options Held

600

Put Options Held

900

View Full List

About IRADIMED CORP

Ticker IRMD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 12,565,100
Market Cap $707M
Description
IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices, and related accessories and services in the United States and internationally. It offers MRidium MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; and MRI compatible pati...

More about IRMD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Iradimed Corp Transaction History